Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$5.9 - $8.02 $3,681 - $5,004
624 New
624 $4,000
Q2 2023

Aug 01, 2023

SELL
$9.99 - $18.27 $4,625 - $8,459
-463 Reduced 86.06%
75 $0
Q1 2023

Apr 28, 2023

BUY
$15.0 - $22.76 $8,070 - $12,244
538 New
538 $8,000
Q2 2022

Aug 10, 2022

SELL
$13.31 - $34.88 $678 - $1,778
-51 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$20.26 - $32.36 $1,033 - $1,650
51 New
51 $2,000
Q4 2021

Jan 25, 2022

SELL
$26.0 - $37.03 $12,870 - $18,329
-495 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$29.75 - $37.99 $14,726 - $18,805
495 New
495 $16,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $588M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.